“…In our study enrolling 100 consecutive patients with type 2 diabetes (T2D), 64 had sleep apnea syndrome (SAS; SAS prevalence 64%), as assessed by a portable sleep diagnostic device (ApneaLink; ResMed, Poway, CA, USA), and we showed that patients with SAS had poorer diabetes control than those without SAS (HbA1c 8.4% vs 7.6%, respectively P = 0.04) . After adjustment for age, gender, diabetes duration, diabetes treatment, and body mass index, HbA1c was associated with mean and lowest O 2 saturation during sleep (β = −0.23 [ P = 0.03] and β = −0.24 [ P = 0.007], respectively).…”